Author:
Owen Dwight H.,Giffin Michael J.,Bailis Julie M.,Smit Marie-Anne Damiette,Carbone David P.,He Kai
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Biology,Hematology
Reference51 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
2. Hirsch FR, Suda K, Wiens J, Bunn PA Jr. New and emerging targeted treatments in advanced non-small-cell lung cancer. Lancet. 2016;388(10048):1012–24.
3. Powell HA, Tata LJ, Baldwin DR, Potter VA, Stanley RA, Khakwani A, et al. Treatment decisions and survival for people with small-cell lung cancer. Br J Cancer. 2014;110(4):908–15.
4. Horn L, Mansfield AS, Szczesna A, Havel L, Krzakowski M, Hochmair MJ, et al. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N Engl J Med. 2018;379(23):2220–9.
5. Genentech, Inc. Tecentriq (atezolizumab) [package insert]. U.S. Food and Drug Administration
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761034s010lbl.pdf
. Revised June 2018.
Cited by
112 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献